Skip to main content
Clinical Trials/KCT0004437
KCT0004437
Completed
未知

Clinical research of comparative effectiveness and safety of JHG002 for chronic temporomandibular joint dysfunction: A multicenter randomized controlled trial)

Jaseng Medical Foundation0 sites82 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the digestive system
Sponsor
Jaseng Medical Foundation
Enrollment
82
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 21, 2021
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients with unilateral or bilateral TMJ pain
  • (2\) Patients with VAS \= 40mm for the area showing TMJ pain (for patients with bilateral pain, the side with worse pain)
  • (3\) Patients complaining of persistent of sporadic TMJ pain for at least 3 months
  • (4\) Patients diagnosed as myofascial TMD (Axis I: Group 1\) based on the RDC/TMD diagnostic criteria \[5]
  • (5\) Patients aged 19–70 years on the date they sign the consent form
  • (6\) Patients who provide consent to participate in the trial and return the informed consent form

Exclusion Criteria

  • (1\) Patients whose current pain episode developed or worsened because of a road traffic accident or traumatic injury
  • (2\) Patients diagnosed in Group 2 or 3 of Axis I based on the RDC/TMD diagnostic criteria
  • (3\) Patients who have undergone surgery related to the TMJ
  • (4\) Patients with other chronic diseases that could interfere with interpretation of the treatment effects or outcomes (e.g., rheumatoid arthritis, neoplastic disease, stroke, or myocardial infarction)
  • (5\) Patients currently taking steroids, immunosuppressants, psychiatric drugs, or other drugs that could affect the study results
  • (6\) Patients who have received HPP within the last month, or who have taken drugs that could affect pain, such as NSAIDs, within the last week
  • (7\) Pregnant or breastfeeding women
  • (8\) Patients who have finished participation in another clinical trial within the last month, who participated in another trial within 6 months of selection, or who are planning to participate in another clinical trial during the follow\-up period
  • (9\) Patients with a history of hypersensitivity after HPP
  • (10\) Diabetic patients with uncontrolled blood glucose (fasting blood glucose \= 180mg/dl)

Outcomes

Primary Outcomes

Not specified

Similar Trials